Bank of New York Mellon’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $837K | Buy |
347,229
+52,982
| +18% | +$128K | ﹤0.01% | 3206 |
|
|
2025
Q1 | $650K | Sell |
294,247
-21,047
| -7% | -$46.5K | ﹤0.01% | 3300 |
|
|
2024
Q4 | $1.72M | Sell |
315,294
-83,940
| -21% | -$457K | ﹤0.01% | 2816 |
|
|
2024
Q3 | $3.32M | Sell |
399,234
-107,179
| -21% | -$891K | ﹤0.01% | 2504 |
|
|
2024
Q2 | $3.63M | Buy |
506,413
+117,120
| +30% | +$839K | ﹤0.01% | 2488 |
|
|
2024
Q1 | $3.38M | Sell |
389,293
-19,499
| -5% | -$169K | ﹤0.01% | 2506 |
|
|
2023
Q4 | $2.68M | Sell |
408,792
-106,331
| -21% | -$696K | ﹤0.01% | 2682 |
|
|
2023
Q3 | $5.15M | Buy |
515,123
+9,592
| +2% | +$95.9K | ﹤0.01% | 2302 |
|
|
2023
Q2 | $6.28M | Sell |
505,531
-99,718
| -16% | -$1.24M | ﹤0.01% | 2198 |
|
|
2023
Q1 | $8.48M | Buy |
605,249
+6,951
| +1% | +$97.4K | ﹤0.01% | 2011 |
|
|
2022
Q4 | $8.56M | Buy |
598,298
+47,122
| +9% | +$674K | ﹤0.01% | 2019 |
|
|
2022
Q3 | $14.1M | Sell |
551,176
-37,361
| -6% | -$954K | ﹤0.01% | 1695 |
|
|
2022
Q2 | $16.7M | Buy |
588,537
+171,920
| +41% | +$4.88M | ﹤0.01% | 1638 |
|
|
2022
Q1 | $14.7M | Buy |
416,617
+6,339
| +2% | +$224K | ﹤0.01% | 1858 |
|
|
2021
Q4 | $17.2M | Buy |
410,278
+49,562
| +14% | +$2.08M | ﹤0.01% | 1813 |
|
|
2021
Q3 | $17.7M | Buy |
360,716
+87,254
| +32% | +$4.28M | ﹤0.01% | 1795 |
|
|
2021
Q2 | $11.4M | Buy |
273,462
+111,832
| +69% | +$4.67M | ﹤0.01% | 2058 |
|
|
2021
Q1 | $5.76M | Buy |
+161,630
| New | +$5.76M | ﹤0.01% | 2379 |
|